Cancer Detection and Diagnosis Research in Kansas
Cancer Detection and Diagnosis Research (93.394) awarded $7.1 million to recipients in Kansas in 8 grants from fiscal 2021 to 2025, 0.3% of the program's national total. University of Kansas Medical Center Research Institute, Inc. received the most, $3.6 million.
- Awarded in Kansas$7.1 million
- Awards8
- Share of the program0.3%
- Rank among states36th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 5 | $1.8 million |
| FY 2022 | 6 | $2.3 million |
| FY 2023 | 5 | $2.1 million |
| FY 2024 | 2 | $429,184 |
| FY 2025 | 1 | $463,640 |
Recipients in Kansas
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Kansas Medical Center Research Institute, Inc. | Other | 2 | $3.6 million |
| University of Kansas Center for Research Inc | Other | 4 | $3.0 million |
| Kansas State University | Colleges and universities | 1 | $437,027 |
| Neotherma Oncology Inc | Small businesses | 1 | $65,753 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Kansas?
$7.1 million from fiscal 2021 to 2025, across 8 awards. Kansas ranks 36th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Kansas?
The largest recipient is University of Kansas Medical Center Research Institute, Inc., with $3.6 million in 2 awards. Next are University of Kansas Center for Research Inc and Kansas State University.
Can organizations in Kansas apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Kansas
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families